Leichter H E, Sheth K J, Gerlach M J, Franklin S, Stevens L, Casale A T
Department of Pediatrics, Medical College of Wisconsin, Milwaukee 53226.
Child Nephrol Urol. 1992;12(1):1-5.
Results of renal transplantation in younger children have not been very encouraging in the past. We therefore studied the effect of newer immunosuppressive regimens on the outcome of renal transplantation of 5 children aged 2.9 +/- 1.3 years (range 1.6-5.0), and compared it to 10 children of an older pediatric patient group aged 11.4 +/- 4.4 years (range 6.0-18.5). All patients with the exception of 1 underwent dialysis. The percentage of cadaveric and live-related transplants was similar in both groups. Recipients of a cadaveric transplant had at least 3 blood transfusions; recipients of live-related transplants had donor-specific transfusions with azathioprine. Posttransplantation immunosuppression consisted of prednisone and azathioprine; recipients of cadaveric transplants received also ciclosporin. Rejection episodes and side effects (hypertension, hirsutism) were comparable in both groups. In the younger patient group, 1 patient died of a congenital lung abnormality but had a functioning graft. In the older patient group, 1 patient lost his graft 16 months posttransplantation due to reduction of his immunosuppressives, necessitated by a severe CMV infection. Growth and development improved in the younger patient group, but was stable in older patients. Renal transplantation is a suitable option in younger pediatric patients. Graft survival rates are comparable to those of older patients.
过去,年幼儿童肾移植的结果并不十分令人鼓舞。因此,我们研究了更新的免疫抑制方案对5名年龄为2.9±1.3岁(范围1.6 - 5.0岁)儿童肾移植结果的影响,并将其与10名年龄较大的儿科患者组(年龄11.4±4.4岁,范围6.0 - 18.5岁)进行比较。除1名患者外,所有患者均接受了透析。两组中尸体供肾移植和亲属活体供肾移植的比例相似。尸体供肾移植受者至少接受了3次输血;亲属活体供肾移植受者接受了与硫唑嘌呤联合的供者特异性输血。移植后免疫抑制包括泼尼松和硫唑嘌呤;尸体供肾移植受者还接受了环孢素。两组的排斥反应和副作用(高血压、多毛症)相当。在年幼儿童患者组中,1名患者死于先天性肺部异常,但移植肾仍有功能。在年龄较大的患者组中,1名患者在移植后16个月因严重巨细胞病毒感染需要减少免疫抑制剂用量,导致移植肾失功。年幼儿童患者组的生长发育有所改善,但年龄较大患者组的生长发育保持稳定。肾移植对于年幼儿科患者是一个合适的选择。移植肾存活率与年龄较大患者相当。